ONC
BeOne Medicines Ltd
201 hedge funds and large institutions have $8.14B invested in BeOne Medicines Ltd in 2023 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 52 increasing their positions, 74 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
4% less capital invested
Capital invested by funds: $8.47B → $8.14B (-$327M)
13% less funds holding in top 10
Funds holding in top 10: 8 → 7 (-1)
30% less repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 74
Holders
201
Holding in Top 10
7
Calls
$14.8M
Puts
$14.1M
Top Buyers
| 1 | +$51.5M | |
| 2 | +$39.6M | |
| 3 | +$31.8M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$28.6M |
| 5 |
Goldman Sachs
New York
|
+$24.6M |
Top Sellers
| 1 | -$198M | |
| 2 | -$182M | |
| 3 | -$114M | |
| 4 |
Canada Life
Winnipeg,
Manitoba, Canada
|
-$53.4M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$9.98M |